Response to correspondence 'Reasons against routine determination of plasma trough levels in PWH treated with intramuscular long acting cabotegravir and rilpivirine as of today'

Clin Infect Dis. 2024 Mar 14:ciae142. doi: 10.1093/cid/ciae142. Online ahead of print.
No abstract available